The global legionella testing market is expected to witness significant growth over the forecast period, owing to the rising prevalence of legionnaires’ disease and increasing awareness regarding its diagnosis and prevention. According to the World Health Organization (WHO), legionnaires' disease is an important cause of severe pneumonia with more than 2000 cases reported annually in Europe and over 25,000 cases reported in the US.
Rising awareness regarding the spread of legionella through water systems has led to the imposition of stringent regulations by governments globally, which is propelling the demand for legionella testing. Furthermore, the increasing investments in research and development activities for the development of effective diagnosis and treatment solutions for legionnaires’ disease is further driving the growth of the market.
Download Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333
The growing demand for advanced water treatment systems and the introduction of innovative testing solutions are some of the major factors expected to drive the growth of the global legionella testing market. Additionally, the rising focus on preventive healthcare and the increasing demand for cost-effective solutions for testing are expected to drive market growth.
The global legionella testing market is segmented based on product type, end user, and region. Based on product type, the market is divided into PCR-based tests, immunoassay tests, and culture tests. The PCR-based tests segment is expected to dominate the market due to their high accuracy and rapid results. By end user, the market is segmented into water treatment companies, hospitals and diagnostic laboratories, and others. The water treatment companies segment is expected to account for the largest market share due to the increasing focus on preventive healthcare.
Geographically, the global legionella testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest market share due to the increasing prevalence of legionnaires’ disease and the presence of well-established healthcare infrastructure.
Key Market Players
The major players in the global legionella testing market are Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Neogen Corporation, Roka Bioscience, Inc., Hygiena, LLC, A to Z Testing, Inc., and Pro-Lab Diagnostics, among others. These companies are focusing on product launches and strategic collaborations to expand their product portfolio and strengthen their market presence.
Overall, the global legionella testing market is expected to witness robust growth over the forecast period, owing to the rising prevalence of legionnaires’ disease and the increasing investments in research and development activities.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173145333
This report categorizes the global legionella testing market into the following segments and subsegments:
By Test Type
- Culture Methods
- Urinary Antigen Tests
- Direct Fluorescent Antibody Tests
- PCR
By Application
- Water Testing
- IVD Testing
- Other Applications
By End User
- Hospitals
- Diagnostic Laboratories
- Water & Other Industries
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In December 2021, IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company’s international reference laboratory presence.
- LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
- Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173145333
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
